These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8929121)

  • 21. [Azithromycin in the therapy of lower respiratory tract infection in children].
    Breborowicz A
    Pol Merkur Lekarski; 2008 Nov; 25(149):420-2. PubMed ID: 19177779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Lower respiratory infections: predictive factors of therapeutic response].
    Bedos JP; Veber B
    Rev Pneumol Clin; 1996; 52 Suppl 2():S47-50. PubMed ID: 9033917
    [No Abstract]   [Full Text] [Related]  

  • 23. [Azithromycin: critical points].
    Philippon A; Cluzel R; Soussy CJ
    Pathol Biol (Paris); 1995 Jun; 43(6):488-97. PubMed ID: 8539070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of moxifloxacin and high-dose levofloxacin in severe lower respiratory tract infections.
    Kontou P; Manika K; Chatzika K; Papaioannou M; Sionidou M; Pitsiou G; Kioumis I
    Int J Antimicrob Agents; 2013 Sep; 42(3):262-7. PubMed ID: 23830621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacokinetic and clinical studies on azithromycin in children].
    Ohtsuka Y; Harada Y; Tsuji Y; Uehara Y; Kido T; Kobayashi N; Hayashi K
    Jpn J Antibiot; 1996 Nov; 49(11):1039-48. PubMed ID: 8988416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macrolides in dermatology.
    Scheinfeld NS; Tutrone WD; Torres O; Weinberg JM
    Dis Mon; 2004 Jul; 50(7):350-68. PubMed ID: 15280867
    [No Abstract]   [Full Text] [Related]  

  • 27. [New therapeutic uses of the macrolides].
    Mihălţan F
    Pneumologia; 2004; 53(3):100-4. PubMed ID: 16108157
    [No Abstract]   [Full Text] [Related]  

  • 28. [In vitro and in vivo antibacterial activities of azithromycin].
    Miyazaki S; Yamaguchi K
    Jpn J Antibiot; 2000 Jun; 53 Suppl B():22-42. PubMed ID: 12572087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The evolution of antimicrobial agents used for the management of CARTIs: a focus on a new class of antimicrobials--the ketolides.
    Sbarbaro JA
    Am J Manag Care; 2004 Oct; 10(12 Suppl):S389-99. PubMed ID: 15603248
    [No Abstract]   [Full Text] [Related]  

  • 30. Cethromycin: a promising new ketolide antibiotic for respiratory infections.
    Rafie S; MacDougall C; James CL
    Pharmacotherapy; 2010 Mar; 30(3):290-303. PubMed ID: 20180612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The newer macrolides. Azithromycin and clarithromycin.
    Zuckerman JM; Kaye KM
    Infect Dis Clin North Am; 1995 Sep; 9(3):731-45. PubMed ID: 7490441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-dose azithromycin for respiratory tract infections.
    Law C; Amsden GW
    Ann Pharmacother; 2004 Mar; 38(3):433-9. PubMed ID: 14970367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Azithromycin and clarithromycin.
    Schlossberg D
    Med Clin North Am; 1995 Jul; 79(4):803-15. PubMed ID: 7791424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparison of antimicrobial resistance pattern of selected respiratory tract pathogens isolated from different animal species].
    Wettstein K; Frey J
    Schweiz Arch Tierheilkd; 2004 Sep; 146(9):417-22. PubMed ID: 15481587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical cure rates in subjects treated with azithromycin for community-acquired respiratory tract infections caused by azithromycin-susceptible or azithromycin-resistant Streptococcus pneumoniae: analysis of Phase 3 clinical trial data.
    Zhanel GG; Wolter KD; Calciu C; Hogan P; Low DE; Weiss K; Karlowsky JA
    J Antimicrob Chemother; 2014 Oct; 69(10):2835-40. PubMed ID: 24920652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [In vitro activity of several antibiotics on pathogenic micro-organisms isolated from the lower respiratory tract].
    Allocco A; Tullio V; Cuffini AM; Carlone NA
    G Batteriol Virol Immunol; 1994; 86(1-12):15-28. PubMed ID: 8706972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bacterial pathogens (non-Mycobacterium) from sputum culture and antimicrobial susceptibility.
    Srifuengfung S; Sangsawang M; Komolpis P; Dhiraputra C; Chompanee B
    Southeast Asian J Trop Med Public Health; 1998 Mar; 29(1):96-9. PubMed ID: 9740278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Efficacy and safety of levofloxacin in low respiratory tract infection].
    Zubkov MN
    Antibiot Khimioter; 2004; 49(5):31-7. PubMed ID: 15573900
    [No Abstract]   [Full Text] [Related]  

  • 39. Bactericidal effect of propolis in vitro against agents causing upper respiratory tract infections.
    Focht J; Hansen SH; Nielsen JV; van den Berg-Segers A; Riezler R
    Arzneimittelforschung; 1993 Aug; 43(8):921-3. PubMed ID: 8216454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reversibility of antimicrobial resistance in respiratory isolates in HIV-positive Cambodian children after 36 months of HAART.
    Shahum A; Benca G; Duong LS; Augustin A; Havlik S; Liska A; Kalavsky E; Beno P; Krcmery V
    J Antimicrob Chemother; 2007 Jul; 60(1):194-7. PubMed ID: 17545143
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.